Skip to main content

View full-text article in PMC

. 2018 Feb 1;235(4):1107–1119. doi: 10.1007/s00213-018-4828-5

Table 1.

Demographic and baseline characteristics

	Treatment sequence 1^an = 12	Treatment sequence 2^bn = 12
Age (years)
Mean (SD)	23.7 (8.07)	27.0 (7.86)
Gender, n (%)
Male	6 (50)	6 (50)
Race, n (%)
White	11 (92)	11 (92)
Other	1 (8)	0
Black or African American	0	1 (8)
Ethnicity, n (%)
Not Hispanic or Latino	10 (83)	12 (100)
Hispanic or Latino	2 (17)	0
BMI (kg/m²)
Mean (SD)	22.7 (2.81)	24.4 (3.67)

BMI body mass index, SD standard deviation

^aIntranasal esketamine 84 mg/intranasal placebo

^bIntranasal placebo/intranasal esketamine 84 mg